Atara Biotherapeutics
ATRA • NASDAQ
Atara Biotherapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Anhco Nguyen, with a market cap of $39.5M.
Market Cap$39.5M
Employees173.0
CEOAnhco Nguyen
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Atara Biotherapeutics FAQ
Common questions about Atara Biotherapeutics
Atara Biotherapeutics is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $2.2M.
Atara Biotherapeutics has approximately 173 employees.